Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/BO1 stock hub

FRA/BO1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/BO1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/BO1FRA/BO1

—

Loading chart…

In the news

Latest news · FRA/BO1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC431.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/BO1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	435
Employees Change	44%
Employees Change Percent	8.21
Enterprise value	EUR 2.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.9B
Price	EUR 7.49
Price currency	EUR
Rev Per Employee	1,765,934.45x
Sic	2836
Symbol	fra/BO1
Website	https://www.biocryst.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.34%
EV Earnings	-6.01x
EV/EBIT	8.72x
EV/EBITDA	8.55x
EV/FCF	8.87x
EV/Sales	3.17x
FCF yield	14.46%
Forward P/E	19.09x
P/B ratio	-3.88x
P/S ratio	2.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	36.38%
EBITDA Margin	36.86%
FCF margin	35.04%
Gross margin	76.63%
Gross Profit	EUR 588.6M
Gross Profit Growth	109.67%
Gross Profit Growth Q	-12.52%
Gross Profit Growth3 Y	145.16%
Net Income	EUR -397.2M
Pretax Margin	-51.28%
Profit Margin	-51.71%
Profit Per Employee	EUR -913,123
ROA	42.62
Roa5y	-1.78
ROCE	119.5
ROIC	431.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.33%
Cagr15y	8.52%
Cagr1y	-17.37%
Cagr3y	-0.63%
Cagr5y	-6.36%
Revenue Growth	75.92x
Revenue Growth Q	7.48x
Revenue Growth3 Y	45.14x
Revenue Growth5 Y	94.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.87
Assets	EUR 403.3M
Cash	EUR 206.8M
Current Assets	EUR 316.8M
Current Liabilities	EUR 165.7M
Debt	EUR 744.2M
Debt EBITDA	EUR 2.61
Debt FCF	EUR 2.76
Equity	EUR -480.3M
Interest Coverage	4.29
Liabilities	EUR 883.7M
Long Term Assets	EUR 86.5M
Long Term Liabilities	EUR 718M
Net Cash	EUR -537.5M
Net Cash By Market Cap	EUR -28.87
Net Debt EBITDA	EUR 1.9
Net Debt FCF	EUR 2
Tangible Book Value	EUR -480.3M
Tangible Book Value Per Share	EUR -1.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.91
Inventory Turnover	32.2
Net Working Capital	EUR -14.5M
Quick ratio	1.78
Working Capital	EUR 154.6M
Working Capital Turnover	EUR 3.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	219.85%
1Y total return	-17.36%
200-day SMA	6.67
3Y total return	-1.89%
50-day SMA	7.73
50-day SMA vs 200-day SMA	50over200
5Y total return	-28.01%
All Time High	17.18
All Time High Change	-56.37%
All Time High Date	2022-02-17
All Time Low	0.89
All Time Low Change	744.87%
All Time Low Date	2013-03-04
ATR	0.23
Ch YTD	16.26
High	7.49
High52	10.19
High52 Date	2026-03-24
High52ch	-26.42%
Low	7.49
Low52	5.18
Low52 Date	2026-02-06
Low52ch	44.62%
Ma50ch	-3.02%
Price vs 200-day SMA	12.42%
RSI	46.5
RSI Monthly	51.98
RSI Weekly	55.13
Sharpe ratio	-0.16x
Sortino ratio	-0.12
Total Return	-5.23%
Tr YTD	16.26
Tr15y	240.95%
Tr1m	-9.3%
Tr1w	-1.39%
Tr3m	44.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 279.5M
Operating Income Growth	835.8
Operating margin	36.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	221,543,490%
Net Borrowing	55,064,108.4
Shares Insiders	0.96%
Shares Institutions	76.61%
Shares Qo Q	10.49%
Shares Yo Y	5.23%
Short Ratio	7.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 200M
Average Volume	253.1x
Bv Per Share	-1.89
CAPEX	EUR -2.4M
Ch10y	219.8
Ch15y	240.9
Ch1m	-9.3
Ch1w	-1.39
Ch1y	-17.36
Ch3m	44.62
Ch3y	-1.89
Ch5y	-28.01
Ch6m	22.93
Change	0.86%
Change From Open	0.05
Close	7.43
Days Gap	0.81
Depreciation Amortization	3,576,703.7
Earnings Date	2026-05-06
EBIT	EUR 279.5M
EBITDA	EUR 283.1M
EPS	EUR -1.82
F Score	5
FCF	EUR 269.2M
FCF EV Yield	11.27x
Financing CF	53,852,392
Fiscal Year End	December
Founded	1,986
Income Tax	EUR 3.3M
Investing CF	-268,374,710
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	6.57
Ma150ch	14.01%
Ma20	7.73
Ma20ch	-3%
Net CF	57,672,848
Open	7.49
P FCF Ratio	6.91
P OCF Ratio	6.85
Ppne	19,490,406.6
Price Date	2026-05-08
Price EBITDA	EUR 6.57
Relative Volume	0.24x
Revenue	768,181,487x
SBC By Revenue	9x
Share Based Comp	69,145,493
Tax By Revenue	0.43x
Tr6m	22.93%
Volume	0
Z Score	-1.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/BO1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/BO1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/BO1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.6%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/BO1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

+12.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/BO1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/BO1 stock rating?

fra/BO1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/BO1 analysis?

The full report lives at /stocks/fra/BO1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/BO1?

The latest report frames fra/BO1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/BO1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.